Which trial do we need? Plasma metagenomic next-generation sequencing to diagnose infections in patients with haematological malignancies and febrile neutropenia: proposal for a randomized-controlled trial
Clinical Microbiology and Infection · 2023-12 · 29 (12) · 1474-1479
DOI: 10.1016/j.cmi.2023.05.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2023-12. Verfasst von Catherine A Hogan und 6 weiteren Autor:innen. Beteiligte Einrichtung: British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada; Department of Pathology, University of British Columbia, Vancouver,…. Hauptthemen laut MEDLINE: Febrile Neutropenia, Hematologic Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada.
- Delve Bio, San Francisco, CA, USA; Department of Laboratory Medicine, University of California, San Francisco, CA, USA.
- Emory University Department of Medicine, Division of Infectious Diseases, Atlanta, GA, USA; Emory University Department of Pathology and Laboratory Medicine, Atlanta, GA, USA.
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Solna, Sweden.
Förderung
- NCI NIH HHS
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Hogan, C. A., Miller, S., Piantadosi, A., Gaston, D. C., Simner, P. J., Nash, S., & Babady, N. E. (2023). Which trial do we need? Plasma metagenomic next-generation sequencing to diagnose infections in patients with haematological malignancies and febrile neutropenia: proposal for a randomized-controlled trial. Clinical Microbiology and Infection, 29(12), 1474-1479. https://doi.org/10.1016/j.cmi.2023.05.024
Vancouver
Hogan CA, Miller S, Piantadosi A, Gaston DC, Simner PJ, Nash S, et al. Which trial do we need? Plasma metagenomic next-generation sequencing to diagnose infections in patients with haematological malignancies and febrile neutropenia: proposal for a randomized-controlled trial. Clinical Microbiology and Infection. 2023;29(12):1474-1479. doi:10.1016/j.cmi.2023.05.024
BibTeX
@article{Hogan2023,
author = {Hogan, Catherine A and Miller, Steve and Piantadosi, Anne and Gaston, David C and Simner, Patricia J and Nash, Stephen and Babady, N Esther},
title = {Which trial do we need? Plasma metagenomic next-generation sequencing to diagnose infections in patients with haematological malignancies and febrile neutropenia: proposal for a randomized-controlled trial},
journal = {Clinical Microbiology and Infection},
year = {2023},
volume = {29},
number = {12},
pages = {1474--1479},
doi = {10.1016/j.cmi.2023.05.024}
}
EUVIMED